Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 13, 2010Journal of Clinical Oncology

Second Malignancy Risks After Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia: Differences by Lymphoma Subtype

View Full Paper
Ask AI
Bookmark
Share

Authors

LMLindsay M. MortonNational Institutes of HealthRCRochelle E. CurtisNational Cancer InstituteMartha S. LinetMartha S. LinetUniversity of North Carolina at Chapel Hill

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Morton et al. (2010) studied this question.

synapsesocial.com/papers/6a879eaf45672ce71af3e6aehttps://doi.org/10.1200/jco.2010.29.1112
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Population-Based Surveillance of HIV-Associated Cancers: Utility of Cancer Registry Data2004 · 27 citations
  2. 2How I treat indolent lymphoma2007 · 114 citations
  3. 3Risk of second malignant neoplasms among lymphoma patients with a family history of cancer2006 · 46 citations
  4. 4Secondary malignancies after treatment for indolent non-Hodgkin's lymphoma: a 16-year follow-up study2008 · 106 citations
  5. 5Risk of Second Malignancy After Non-Hodgkin's Lymphoma: A British Cohort Study2006 · 175 citations